Peptide therapeutics that meet the challenges of modern medicine
Endevica’s novel peptidomimetics overcome the current limitations of small molecules, antibodies and other modalities to treat conditions safely, effectively and with minimal side effects.
Kalohexis is a clinical-stage biotechnology company advancing a portfolio of melanocortin drug candidates for the treatment of metabolic disorders, such as obesity and cancer cachexia